Classic Galactosemia has emerging NIH research funding with 5 grants totaling $1.6M.
NIH fiscal year (Oct–Sep)
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Classic Galactosemia. Strongest funded area: Gene Therapy / Cell Therapy. Largest gap: Epidemiology / Natural History.
5 publications in Case Report / Case Series but no NIH-funded grants found in Epidemiology / Natural History for classic galactosemia. Existing research activity suggests this may be a viable area for grant applications.
7 publications in Epidemiology / Natural History but no NIH-funded grants found in Epidemiology / Natural History for classic galactosemia. Existing research activity suggests this may be a viable area for grant applications.
Track funding opportunities for Classic Galactosemia.
Follow this disease to be notified about new NIH grants and funding changes.
Already have an account? Sign in to manage your watchlists.